Trials / Completed
CompletedNCT01391351
Search for Predictors of Therapeutic Response in Ovarian Carcinoma
Search for Predictors of Therapeutic Response in Patients With Carcinoma of the Ovary, the Fallopian Tube or Peritoneal Serous-type Advanced
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- Centre Francois Baclesse · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In order to search for predictors of response to chemotherapy in patients with ovarian carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage, we will define the comparative profiles of miRNA expression of serum polymorphisms and determine differential in 2 patient populations (with or without recurrence 6 months after completion of chemotherapy) with (i) the miRNA profile of serum before treatment and (ii) identification of polymorphisms or SNP (Single Nucleotide Polymorphism) in particular genes involved in the metabolism of chemotherapy agents In the case of miRNA, expression profiles will also be studied during the first course in response to chemotherapy. Indeed, the miRNA profile of serum may be different at baseline among the 2 types of populations (or non-recurrence at 6 months).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood samples | blood samples in patients receiving Taxol and carboplatin chemotherapy : * On Day 1 of the first course of chemotherapy * On Day 1 of the second course of chemotherapy * Before the surgery, if programmed via J1 or the fourth cycle of chemotherapy * At the end of chemotherapy |
| OTHER | blood samples | blood samples in patients receiving Taxol and carboplatin chemotherapy with avastin: * On Day 1 of the first course of chemotherapy * On Day 1 of the second course of chemotherapy * Before the surgery, if programmed via J1 or the fourth cycle of chemotherapy * At the end of chemotherapy |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2015-11-01
- Completion
- 2016-07-01
- First posted
- 2011-07-12
- Last updated
- 2016-07-21
Locations
7 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01391351. Inclusion in this directory is not an endorsement.